AEON Biopharma, Inc.
AEON- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001837607
In the last 90 days, AEON Biopharma, Inc. insiders filed 1 open-market purchase and 0 sales; 22 institutions reported holding it in 13F filings for Q2 2026, worth $9.22M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in AEON Biopharma, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- +7 vs. Q4 2023
- Shares held
- 9.47M
- +805.8K (+9.3%) vs. Q4 2023
- Total value
- $103.5M
- +$46.7M (+82.2%) vs. Q4 2023
- New holders
- 8
- 11 more added
- Sold out
- 1
- 3 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AEON on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 22 | $9.22M |
| Q1 2026 | 24 | $2.80M |
| Q4 2025 | 22 | $1.67M |
| Q3 2025 | 21 | $1.10M |
| Q2 2025 | 18 | $585.7K |
| Q1 2025 | 16 | $884.8K |
| Q4 2024 | 37 | $4.80M |
| Q3 2024 | 30 | $10.1M |
| Q2 2024 | 25 | $8.73M |
| Q1 2024 | 27 | $103.5M |
| Q4 2023 | 20 | $56.8M |
| Q3 2023 | 16 | $29.3M |
| Q2 2023 | 17 | $12.0M |
| Q1 2023 | 21 | $19.6M |
| Q4 2022 | 86 | $248.3M |
| Q3 2022 | 81 | $226.5M |
| Q2 2022 | 73 | $213.1M |
| Q1 2022 | 71 | $202.3M |
| Q4 2021 | 73 | $192.0M |
| Q3 2021 | 59 | $171.8M |
| Q2 2021 | 47 | $126.0M |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding AEON Biopharma, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Macquarie Group Ltd | 901 | $10 | 0.00% | +901 | New |
| DuPont Capital Management Corp | 3 | $35 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 139 | $1.61K | 0.00% | +2+1.5% | Added |
| Catalyst Funds Management Pty Ltd | 285 | $3.31K | 0.00% | +285 | New |
| Tower Research Capital LLC (TRC) | 967 | $11.2K | 0.00% | +868+876.8% | Added |
| GHP Investment Advisors, Inc. | 1,095 | $12.7K | 0.00% | 00.0% | Unchanged |
| LMR Partners LLP | 6,608 | $76.7K | 0.00% | +6,608 | New |
| Y-Intercept (Hong Kong) Ltd | 10,001 | $116.0K | 0.01% | +10,001 | New |
| Morgan Stanley | 10,404 | $120.7K | 0.00% | +8,604+478.0% | Added |
| Royal Bank of Canada | 14,400 | $167.0K | 0.00% | +14,400 | New |
| Shaolin Capital Management LLC | 21,380 | $248.0K | 0.01% | +21,380 | New |
| Bank of America Corp | 22,995 | $266.7K | 0.00% | −358−1.5% | Reduced |
| JPMorgan Chase & Co | 28,498 | $330.6K | 0.00% | +21,609+313.7% | Added |
| Jane Street Group, LLC | 36,250 | $420.5K | 0.00% | +36,250 | New |
| Northern Trust Corp | 48,813 | $566.2K | 0.00% | −1,006−2.0% | Reduced |
| Boothbay Fund Management, LLC | 55,062 | $638.7K | 0.02% | 00.0% | Unchanged |
| Millennium Management LLC | 55,987 | $649.4K | 0.00% | +55,987 | New |
| State Street Corp | 59,550 | $690.8K | 0.00% | +49,500+492.5% | Added |
| Qube Research & Technologies Ltd | 59,815 | $693.9K | 0.00% | +55,891+1,424.3% | Added |
| Formidable Asset Management, LLC | 68,193 | $791.0K | 0.13% | +10,000+17.2% | Added |
| Goldman Sachs Group Inc | 169,158 | $1.96M | 0.00% | +150,615+812.2% | Added |
| Geode Capital Management, LLC | 179,595 | $2.08M | 0.00% | +7,349+4.3% | Added |
| BlackRock Inc. | 255,423 | $2.96M | 0.00% | +8,335+3.4% | Added |
| Ikarian Capital, LLC | 257,977 | $2.99M | 0.81% | 00.0% | Unchanged |
| Vanguard Group Inc | 758,992 | $8.80M | 0.00% | +549,207+261.8% | Added |
| Atalaya Capital Management LP | 3,675,000 | $36.2M | 42.59% | 00.0% | Unchanged |
| Polar Asset Management Partners Inc. | 3,675,000 | $42.6M | 1.14% | −200,000−5.2% | Reduced |
| UBS Group AG | 0 | $0 | 0.00% | −649−100.0% | Sold out |